ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

COLL Collegium Pharmaceutical Inc

36.42
0.58 (1.62%)
Last Updated: 15:14:48
Delayed by 15 minutes

Period:

Draw Mode:

Volume 69,546
Bid Price 36.44
Ask Price 36.53
News -
Day High 36.57

Low
20.83

52 Week Range

High
40.95

Day Low 35.79
Company Name Stock Ticker Symbol Market Type
Collegium Pharmaceutical Inc COLL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.58 1.62% 36.42 15:14:48
Open Price Low Price High Price Close Price Prev Close
35.95 35.79 36.57 35.84
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,666 69,546 $ 36.30 $ 2,524,348 - 20.83 - 40.95
Last Trade Time Type Quantity Stock Price Currency
15:14:48 3 $ 36.46 USD

Collegium Pharmaceutical Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.16B 31.96M - 566.77M 48.16M 1.51 24.16
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Collegium Pharmaceutical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No COLL Message Board. Create One! See More Posts on COLL Message Board See More Message Board Posts

Historical COLL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week34.6536.5734.2435.45420,8781.775.11%
1 Month38.5440.4934.2436.83342,364-2.12-5.50%
3 Months33.4440.9531.3436.76430,2742.988.91%
6 Months21.8840.9520.9532.58419,10114.5466.45%
1 Year22.7040.9520.8328.43362,39413.7260.44%
3 Years23.3640.9514.0423.67333,74813.0655.91%
5 Years14.5740.9510.0121.63368,60221.85149.97%

Collegium Pharmaceutical Description

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol.

Your Recent History

Delayed Upgrade Clock